Onclave Therapeutics
Records under this name other than patents Onclave Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Onclave Therapeutics
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,268,973 | Anti-amyloid antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,404,815 | Chimeric, Humanized, or Human Antibody 2A4 Formerly held In force · High confidence | In force | High confidence | |
| US 8,636,981 | Detection of Amyloid Deposits Using Anti-Amyloid Antibodies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,928,203 | Chimeric, Humanized, or Human Antibody 2A4 Formerly held In force · High confidence | In force | High confidence | |
| US 9,089,529 | Antibody formulations and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,884,020 | Antibody formulations and methods for treating AL amyloidosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,517,830 | Antibody formulations and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,791,243 | Treatment and Prophylaxis of Amyloidosis Formerly held Lapsed on the fee record Ended Jul 29, 2026 · High confidence | Lapsed on the fee record | Ended Jul 29, 2026 | High confidence |
| US 7,977,316 | Prevention and Treatment of Amyloidogenic Diseases Lapsed on the fee record Ended Jul 12, 2019 · Medium confidence | Lapsed on the fee record | Ended Jul 12, 2019 | Medium confidence |